12/19
09:07 am
maia
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings [Yahoo! Finance]
Low
Report
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings [Yahoo! Finance]
12/19
08:47 am
maia
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
Medium
Report
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
12/16
08:41 am
maia
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas [Yahoo! Finance]
Low
Report
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas [Yahoo! Finance]
12/16
08:37 am
maia
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
Low
Report
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
12/9
06:00 pm
maia
MAIA Biotechnology Announces Private Placement of Approximately $950,000
Low
Report
MAIA Biotechnology Announces Private Placement of Approximately $950,000
12/3
08:17 am
maia
MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
Medium
Report
MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
11/7
08:47 am
maia
MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
Low
Report
MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
11/5
09:47 am
maia
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]
Low
Report
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]
11/5
09:45 am
maia
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
Medium
Report
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
10/30
11:00 am
maia
Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 39th Annual Meeting
Low
Report
Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 39th Annual Meeting
10/28
07:00 pm
maia
MAIA Biotechnology Announces $2.44 Million Private Placement
Medium
Report
MAIA Biotechnology Announces $2.44 Million Private Placement
10/15
08:15 am
maia
MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics
Neutral
Report
MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics